d-limonene is a naturally occurring monoterpene and has been found to posses numerous therapeutic properties. In this study, we used d-limonene as a protective agent against the nephrotoxic effects of anticancer drug doxorubicin (Dox). Rats were given d-limonene at doses of 5% and 10% mixed with diet for 20 consecutive days. Dox was give at the dose of 20 mg/kg body weight intraperitoneally. The protective effects of d-limonene on Dox-induced oxidative stress and inflammation were investigated by assaying oxidative stress biomarkers, lipid peroxidation, serum toxicity markers, proinflammatory cytokines, and expression of nuclear factor kappa B (NFκB), cyclo-oxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) and Nitrite levels. Administration of Dox (20 mg/kg body weight) in rats enhanced renal lipid peroxidation; depleted glutathione content and anti-oxidant enzymes; elevated levels of kidney toxicity markers viz. kidney injury molecule-1 (KIM-1), blood urea nitrogen (BUN), and creatinine; enhanced expression of NFκB, COX-2, and iNOS and nitric oxide. Treatment with d-limonene prevented oxidative stress by restoring the levels of antioxidant enzymes, further both doses of 5% and 10% showed significant decrease in inflammatory response. Both the doses of d-limonene significantly decreased the levels of kidney toxicity markers KIM-1, BUN, and creatinine. d-limonene also effectively decreased the Dox induced overexpression of NF-κB, COX-2, and iNOS and nitric oxide. Data from the present study indicate the protective role of d-limonene against Dox-induced renal damage.
ChenYJungsuwadeePVoreMButterfieldDAClairDK. Collateral damage in cancer chemotherapy: oxidative stress in non targeted tissues. Mol Interv2007; 7: 147–56.
2.
HandaKSatoS. Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. Gann1975; 66: 43–7.
3.
GutteridgeJM. Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin–iron(III) complex. Biochem Pharmacol1984; 33: 1725–8.
4.
SaadSYNajjarTAAl-RýkabyAC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res2011; 43: 211–8.
5.
PritsosCAMaJ. Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chem Biol Interact2000; 127: 1–11.
6.
FadilliogluEErdoganH. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res2003; 47: 317–22.
7.
GhoshJDasJMannaPSilPC. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials2011; 32: 4857–66.
8.
MosserDMZhangX. Interleukin-10: new perspectives on an old cytokine. Immunol Rev2008; 226: 205–18.
9.
MohamedRHKarambRAAmercMG. Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-α, iNOS and NF-κB. Brain Res Bull2011; 86: 22–8.
10.
UchidaYItohMTaguchiYYamaokaSUmeharaHIchikawaSHirabayashiYHolleranWMOkazakiT. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells. Cancer Res2004; 1(64): 6271–9.
11.
AluiseCDMiriyalaSNoelTSultanaRJungsuwadeePTaylorTJCaiJPierceWMVoreMMoscowJASt ClairDK. Butterfield DA 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic Biol Med2011; 50: 1630–8.
12.
ArjumandWSethASultanaS. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats. Food Chem Toxicol2011; 49: 2013–21..
13.
RashidSAliNNafeesSAhmadSTArjumandWHasanSKSultanaS. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods2013; 23: 337–45.
14.
ChristopherDAMiriyalaSNoelTSultanaRJungsuwadeePTaylorTJCaiJPierceWMVoreMMoscowJAClairDKSt, ButterfieldDA. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic Biol Med2011; 50: 1630–8.
15.
AdderleySRFitzgeraldDJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem1999; 274: 5038–46.
16.
SingleteryK. Diet, natural products and cancer chemoprevention. J Nutr2000; 130: 465–6.
17.
PatelNJosephCCorcoranGBRaySD. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol2010; 245: 143–52.
18.
YilmazSAtessahinASahnaEKarahanIOzerS. Protective effect of lycopene on adriamycin-induced nephrotoxicity and nephrotoxicity. Toxicology2006; 218: 164–71.
19.
AjithTAAswathyMSHemaU. Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity. Food Chem Toxicol2008; 46: 3178–3181.
20.
MohanMKambleSGadhiPKastureS. Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food Chem Toxicol2010; 48: 436–40.
21.
OktemGUysalAOralOSezerEDOlukmanMErolAAkgurSABilirA. Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis. Exp Toxicol Pathol2012; 64: 471–9..
22.
Kesterson JW, Hendrickson R, Braddock RJ. Florida citrus oils. Technical Bulletin 749. Gainesville, FL. University of Florida Institute of Food and Agricultural Sciences, 1971; 3–74.
23.
ZhaoCZengYWanMLiRLiangYLiCZengZChauFT. Comparative analysis of essential oils from eight herbal medicines with pungent flavor and cool nature by GC-MS and chemometric resolution methods. J Sep Sci2009; 32: 660–70.
24.
CrowellPLElsonCEBaileyHHElegbedeAHaagJDGouldMN. Human metabolism of the experimental cancer therapeutic agent d-limonene. Cancer Chemother Pharmacol1994; 35: 31–7.
25.
VigushinDMPoonGKBoddyAEnglishJHalbertGWPagonisCJarmanMCoombesRC. Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol1998; 42: 111–7.
26.
AntunesLMGTakahashiCS. Olive oil protects against chromosomal aberrations induced by doxorubicin in Wistar rat bone marrow cells. Genet Mol Biol1999; 2: 225–7..
27.
SahnaEParlakpinarHOzerMKOzturkFOzugurluFAcetA. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J Pineal Res2003; 35: 257–61.
28.
BenguedouarLBoussenaneNHKebsaWAlyaneMRouibahHLahouelM. Efficacy of propolis extract against mitochondrial stress induced by antineoplastic agents (doxorubicin and Vinblastin) in rats. Ind J Exp Biol2008; 46: 112–9.
29.
Alves dos SantosaRJordãoAAJrVannucchiHTakahashiCS. Protection of doxorubicin-induced DNA damage by sodium selenite and selenomethionine in Wistar rats. Nutr Res2007; 27: 343–8.
30.
ClaiborneACatalase activity. In: GreenwaldRA (ed). CRC handbook of methods in oxygen radical research, Boca Raton, FL: CRC Press, 1985, pp. 283–4.
31.
HabigWHPabstMJJakobyWB. Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem1974; 249: 7130–9.
32.
JollowDJMitchellJRZampaglioneNGilletteJR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobezene oxide as the hepatotoxic metabolite. Pharmacology1974; 11: 151–151.
33.
MohandasMMarshallJJDugginGGHorvathJSTillerD. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Res1984; 44: 5086–91.
34.
StripeFDella CorteE. The regulation of rat liver xanthine oxidase. J Biol Chem1969; 244: 3855–63.
35.
MarklundSMarklundG. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem1974; 47: 469–74.
36.
WrightJRColbyHDMilesPR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys1981; 206: 296–304.
37.
CarlbergIMannervikB. Glutathione level in rat brain. J Biol Chem1975; 250: 4480–4575.
38.
BensonAMHunkalarMJTalalayP. Increase of NADPH, quinone reductase activity by dietary antioxidant: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA1980; 77: 5116–220..
39.
KornbergALactic dehydrogenase of muscle. In: ColowickSPKaplanNO (eds). Methods in enzymology1955; Vol. I, New York: Academic Press, pp. 441–3.
40.
GreenLCWagnerDAGlogowskiJSkipperPLWishnokJSTannenbaumSR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem1982; 126: 131–8.
41.
PickAKeisariY. Superoxide anion and H2O2 production by chemically elicited peritoneal macrophages—induction by multiple non-phagocytic stimulus. Cell Immunol1981; 59: 301–8.
42.
LowryOHRosebroughNJFarrARandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193: 265–75.
43.
InjacR. Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B. Acute doxorubicin nephrotoxicity in rats with malignant neoplasmcan be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacol Rep2008; 60: 742–9..
De BeerELBottoneAEVoestEE. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur J Pharmacol2001; 415: 1–11.
46.
MarósticaMRJrRocha e SilvacTAAFranchiGCNowillAPastoreaGMHyslopS. Antioxidant potential of aroma compounds obtained by limonene biotransformation of orange essential oil. Food Chem2009; 116: 8–12.
47.
OgunbayodeIIsholaIOOlufunshoA. Protective role of ascorbic acid and alpha tocopherol against acetaminophen-induced nephrotoxicity in rats. Afr J Pharma Sci Pharmacy2010; 1: 96–111.
48.
Bou MatarRNKleinJDSandsJM. Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats. PLoS One2013; 8: e54738.–e54738..
49.
ZhouYVaidyaVSBrownRPZhangJRosenzweigBAThompsonKLMillerTJBonventreJVGoeringPL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci2008; 101: 159–159.
50.
RehmanMUTahirMKhanAQKhanRLateefAOday-O-HamizaQamarWAliFSultanaS. Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB. Toxicol Lett2013; 216: 146–58.
51.
DeepaPRVaralakshmiP. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology2006; 217: 176–83.
52.
FrangogiannisNG. The immune system and cardiac repair. Pharmacol Res2008; 58: 88–111.
53.
IrmakMKFadilliogluESogutSErdoganHGulecMOzerMYagmurcaMGozukaraME. Effects of caffeic acid phenethyl ester and alphatocopherol on reperfusion injury in rat brain. Cell Biochem Funct2003; 26: 783–7.
54.
PacherPLiaudetLBaiPMableyJGKaminskiPMVirágLDebASzabóEUngváriZWolinMSGrovesJTSzabóC. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation2003; 107: 896–904.
55.
Sayed-AhmedMMKhattabMMGadMZOsmanAM. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacol Toxicol2001; 89: 140–4.
56.
AkamaKTVan EldikLJ. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor and NF kappa inducing kinase-dependent signaling mechanism. J Biol Chem2000; 275: 7918–24.
57.
SantoroMGRossiAAmiciC. NF-kappaB and virus infection: who controls whom?EMBO J2003; 22: 2552–60.
58.
SnyderARMorganWF. Differential induction and activation of NF-kappaB transcription complexes in radiation-induced chromosomally unstable cell lines. Environ Mol Mutagen2005; 45: 177–187.
59.
SunJ. d-limonene: safety and clinical applications. Alt Med Rev2007; 12: 2007–2007.
60.
KimYWKimMJChungBYBang duYLimSKChoiSMLimDSChoMCYoonKKimHSKimKBKimYSKwackSJLeeBM. Safety evaluation and risk assessment of d-limonene. J Toxicol Environ Health B Crit Rev2013; 16: 17–38.
